HBLTX | RMYCX | HBLTX / RMYCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 14 years | 10 years | - |
Gain YTD | 7.983 | 5.712 | 140% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12.4B | 304M | 4,079% |
Annual Yield % from dividends | 3.54 | 4.04 | 88% |
Returns for 1 year | 15.43 | 12.47 | 124% |
Returns for 3 years | -0.41 | -5.90 | 7% |
Returns for 5 years | 16.16 | 5.03 | 321% |
Returns for 10 years | 39.33 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PRMSX | 34.53 | -0.10 | -0.29% |
T. Rowe Price Emerging Markets Stock | |||
NUIIX | 29.30 | -0.24 | -0.81% |
Nuveen International Dividend Growth I | |||
SFAAX | 43.17 | -0.36 | -0.83% |
Allspring Index Asset Allocation A | |||
MCSPX | 12.33 | -0.17 | -1.36% |
BlackRock Advantage SMID Cap Inv C | |||
PAXGX | 16.98 | -0.26 | -1.51% |
Impax Global Opportunities Investor |